Heron Therapeutics Inc (NASDAQ:HRTX)

30.20
Delayed Data
As of Jul 02
 -0.65 / -2.11%
Today’s Change
6.51
Today|||52-Week Range
34.03
+200.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization125.0K150.0K189.0K152.0K
 
 
 
 
 
 
Operating ExpensesGross Income-125.0K-150.0K-189.0K-152.0K
 
 
 
 
 
General Expenses18.7M18.8M19.3M20.2M
 
 
 
 
 
Research And Development14.4M14.7M14.2M14.5M
 
 
 
 
 
Total Operating Expenses18.8M19.0M19.5M20.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.8M-19.0M-19.5M-20.4M
 
 
 
 
 
Interest Expense On Debt220.0K241.0K--210.0K
 
 
 
 
Other Expenses0.000.00-1.1M0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.0M-19.2M-20.6M-20.6M
 
 
 
 
 
Net Income-19.0M-19.2M-20.6M-20.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.3M29.0M29.2M29.4M
 
 
 
 
 
Shares To Calculate EPS Diluted24.3M29.0M29.2M29.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.78-$0.66-$0.71-$0.70
 
 
 
 
 
EPS Diluted-$0.78-$0.66-$0.71-$0.70
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account